EnWave presenta los resultados financieros consolidados del cuarto trimestre y anuales de 2024

13 de diciembre de 2024

Delta, BC, December 13, 2024

EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) reported the Company’s consolidated interim financial results for the fourth quarter and fiscal year ended September 30, 2024.  

All values in thousands and denoted in CAD unless otherwise stated.

  • Reported revenue for Q4 2024 of $3,634, representing an increase of $2,177 relative to the comparable period in the prior year.   The increase in revenue was primarily a result of the resale of a large-scale machine and an increase in royalties during the period. 
  • Reported Royalties of $642 for Q4 2024, representing an increase of $261 relative to the comparable period in the prior year.  The increase in royalties was primarily a result of an increase in exclusivity payments driven by a new Commercial License Agreement with an existing royalty partner.   
  • Reported Adjusted EBITDA(1) of $450 for Q4 2024, an increase of $774 from the comparable period in the prior year.
  • Reported Net Income from continuing operations of $588 in Q4 2024, an increase of $1,193 from the comparable period in the prior year.
  • Reported an overall increase in Selling, General & Administrative (“SG&A”) costs (including Research & Development (“R&D”)) of $269 for Q4 2024 relative to the comparable period in the prior year, with the increase primarily related to legal fees, travel costs, marketing, and trade show attendance. 

Consolidated Financial Performance:

($ ‘000s)Three months ended September 30, Year ended September 30,
20242023Change % 20242023Change %
      
Revenues3,6341,457149% 8,18111,363(28%)
Direct costs(2,192)    (1,036)112% (5,522) (6,930)(20%)
     Gross margin1,442421243% 2,6594,433(40%)
        
Operating expenses       
General and administration60443539% 2,3462,1987%
Sales and marketing31922939% 1,4681,3965%
Research and development3673573% 1,4941,577(5%)
 1,2901,02126% 5,3085,1713%
        
Net (loss) income continuing operations588(605)197% (2,350)(1,579)(49%)
Net (loss) income discontinued operations(13)                770(102%) (48)(4,933)99%
Adjusted EBITDA(1)450(324)239% (1,489)379(493%)
Loss per share:       
Basic and diluted – continuous operations   $0.01      $(0.01)  $ (0.02)$ (0.01) 
Basic and diluted – discontinued operations        $(0.00)$ 0.01  $ (0.00)$ (0.05) 
     $0.01$ 0.00  $ (0.02)$ (0.06) 
  • Adjusted EBITDA is a non-IFRS financial measure. Refer to the Non-IFRS Financial Measures disclosure below for a reconciliation to the nearest IFRS equivalent.

EnWave’s annual consolidated financial statements and MD&A are available on SEDAR at www.sedarplus.ca and on the Company’s website www.enwave.net.

Key Financial Highlights for the Year Ended 2024 (expressed in ‘000s):

  • Revenue for the year ended 2024 of $8,181, compared to $11,363 for the year ended 2023, a decrease of $3,182. The decrease in revenue was due to fewer machine sales and machines in fabrication offset by higher royalties compared to 2023.
  • Royalty Revenues for the year ended 2024 of $1,961 compared to $1,465 for the year ended 2023, an increase of $496. The increase in royalties was primarily a result of an increase in exclusivity payments and increased production and sales by current partners. 
  • Gross margin for the year ended 2024 was 33% compared to 39% for the year ended 2023. The decrease in margin was a result of fewer machine sales to absorb fixed costs relative to fiscal 2023.
  • SG&A expenses (including R&D) for the year ended 2024 were $5,308, compared to $5,171 for the year ended 2023, an increase of $137. The increase primarily related to legal fees, travel costs, marketing, and trade show attendance. 
  • Adjusted EBITDA (refer to Non-IFRS Financial Measures section below) for the year ended 2024 was a loss of $1,489, compared to $379 for the year ended 2023, a decrease of $1,868. The decrease in adjusted EBITDA was primarily due to fewer machine sales and machines in fabrication relative to fiscal 2023.

Significant Corporate Accomplishments in Q4 2024 and Subsequently:

  • Signed a Research and Development License and Lease Agreement with ELEA Technology GmbH (“ELEA”).   ELEA will lease a 10kW REV™ machine for use at its German facility beginning in February 2025 for a minimum three-month term. 
  • Signed a Licence Agreement, referral agreement and an Equipment Purchase Agreement for a 10kW REV™ machine with the Spanish National Centre for Food Technology and Safety (“CNTA”).
  • Signed a revolving credit facility agreement with Desjardins Tech & Innovation Banking of the Desjardins Group (“Desjardins”).  The amount available to the Company under the facility is calculated as the lesser of $5 million and a function of royalties, receivables and inventory at an interest rate of Canadian prime plus 1.50%. Additionally, the Company signed a $500K loan agreement with Desjardins with an amortization period of 48 months. The loan is to be repaid monthly on equal and consecutive payments of principal plus interest at a rate of Canadian prime plus 2.00%.
  • Reached global settlements of its civil claim in the Supreme Court of British Columbia against EnWave’s former CEO and three other former EnWave employees (the “Durance Defendants”). Pursuant to the settlement, the Durance Defendants, together with three companies associated with the former CEO, are permanently restrained and enjoined from, directly or indirectly, selling, attempting to sell, supplying, delivering or installing vacuum microwave dryers.  The Durance Defendants, together with three companies associated with the former CEO, are also obligated to assign all issued and pending patents in the name of the Durance Defendants to EnWave.
  • Signed a Commercial Licence Agreement with an existing royalty partner for the right to use EnWave’s proprietary vacuum-microwave dehydration technology in an unspecified Central American country.
  • Hired a new Vice President, Global Sales and Business Development as part of EnWave’s enhanced sales strategy, attracting top-level sales talent and growing the Company’s presence internationally.

Medidas financieras distintas de las NIIF:

This news release refers to Adjusted EBITDA which is a non-IFRS financial measure. We define Adjusted EBITDA as earnings before deducting amortization and depreciation, stock-based compensation, foreign exchange gain or loss, finance expense or income, income tax expense or recovery, non-recurring income and expenses, restructuring and severance charges and discontinued operations. This measure is not necessarily comparable to similarly titled measures used by other companies and should not be construed as an alternative to net income or cash flow from operating activities as determined in accordance with IFRS. Please refer to the reconciliation between Adjusted EBITDA and the most comparable IFRS financial measure reported in the Company’s consolidated financial statements.

 Three months ended September 30,Year ended September 30
 ($ ‘000s) 2024 2023 2024 2023
       
Net (loss) income after income tax575 165(2,398) (6,512)
          Amortization and depreciation298 2761,160 1,117
          Stock-based compensation30 88248 556
          Foreign exchange (gain) loss35 (59)(1) 27
          Finance income(63) (53)(211) (185)
          Finance expense37 29140 128
          Non-recurring (income) expense(475) (475) 315
   Discontinued operations13 (770)48 4,933
Adjusted EBITDA450 (324)(1,489) 379

Non-IFRS financial measures should be considered together with other data prepared accordance with IFRS to enable investors to evaluate the Company’s operating results, underlying performance and prospects in a manner similar to EnWave’s management. Accordingly, these non-IFRS financial measures are intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS. For more information, please refer to the Non-IFRS Financial Measures section in the Company’s MD&A available on www.sedarplus.ca.

Acerca de EnWave

EnWave es líder mundial en innovación y aplicación de la deshidratación por microondas al vacío. Desde su sede en Delta (Columbia Británica), EnWave ha desarrollado una sólida cartera de propiedad intelectual, ha perfeccionado su tecnología Radiant Energy Vacuum (REV™) y ha transformado una idea innovadora en una solución de secado probada, consistente y escalable para las industrias alimentaria, farmacéutica y del cannabis que supera ampliamente a los métodos de secado tradicionales en eficiencia, capacidad, calidad del producto y coste.

Con más de cincuenta socios generadores de royalties repartidos por veintitrés países y cinco continentes, los socios licenciatarios de EnWave están creando aperitivos e ingredientes rentables y nunca vistos, mejorando la calidad y consistencia de sus ofertas existentes, funcionando de forma más eficiente y llegando al mercado más rápidamente con la tecnología patentada de la empresa, la maquinaria licenciada y la orientación de expertos.

La estrategia de EnWave consiste en firmar licencias comerciales sujetas a derechos de autor con productores de alimentos que deseen secar mejor, más rápido y de forma más económica que la liofilización, el secado en bastidor y el secado al aire, y disfrutar de las siguientes ventajas: producir productos nuevos e interesantes, alcanzar niveles óptimos de humedad hasta siete veces más rápido y mejorar el sabor, la textura, el color y el valor nutritivo del producto.

Más información en EnWave.net.

Corporación EnWave

Sr. Brent Charleton, CFA

Presidente y Consejero Delegado

Para más información:

Brent Charleton, CFA, Presidente y Director General, +1 (778) 378-9616
Correo electrónico: bcharleton@enwave.net      

Dylan Murray, CPA, CA, CFO al +1 (778) 870-0729
Correo electrónico: dmurray@enwave.net  

Safe Harbour para declaraciones de información prospectiva: Este comunicado de prensa puede contener información prospectiva basada en las expectativas, estimaciones y proyecciones de la dirección. Todas las declaraciones que se refieran a expectativas o proyecciones sobre el futuro, incluidas las declaraciones sobre la estrategia de crecimiento de la empresa, el desarrollo de productos, la posición en el mercado, los gastos previstos y las sinergias esperadas tras el cierre son declaraciones prospectivas. No se garantiza la exactitud de todas las afirmaciones de terceros a las que se hace referencia en este comunicado. No se garantiza la exactitud de todas las referencias de terceros a información de mercado contenidas en este comunicado, ya que la empresa no ha llevado a cabo la investigación primaria original. Estas afirmaciones no constituyen una garantía de resultados futuros e implican una serie de riesgos, incertidumbres y suposiciones. Aunque la empresa ha intentado identificar los factores importantes que podrían hacer que los resultados reales difirieran materialmente, puede haber otros factores que hagan que los resultados no sean los previstos, estimados o deseados. No puede garantizarse que tales afirmaciones resulten exactas, ya que los resultados reales y los acontecimientos futuros podrían diferir sustancialmente de los previstos en dichas afirmaciones. Por consiguiente, los lectores no deben depositar una confianza indebida en las afirmaciones de carácter prospectivo.

Ni la TSX Venture Exchange ni su Proveedor de Servicios de Regulación (según se define este término en las políticas de la TSX Venture Exchange) aceptan responsabilidad alguna por la adecuación o exactitud de este comunicado.